TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
KOD

Kodiak Sciences Inc

Healthcare · Biotechnology

32.40$ -0.9% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KOD
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-73.2% +2,741.8% +289.3% +197.4% -15.3% -26.3% -28.1% -30.0% +4.8%
-84.3% +5,570.8% +275.1% +186.5% -24.4% -33.9% -40.5% -40.6% +24.9%
-85.5% +6,226.5% +140.0% +345.9% -22.5% -74.0% +49.9% -41.1% +24.9%
-85.5% +6,226.5% +281.3% +188.0% -24.5% -34.5% -40.4% -41.1% +24.9%
-15.0% -27.3% +154.0% +84.4% +2,004.2% -47.8%
+35.3% -92.6% +152.2% +1,429.5% +16.6% -4.3% -7.3% -13.3% +4.8%
+265.2% -47.3% +142.7% +168.3% +105.9% -18.8% -20.5% -38.7% +78.1%
+31.7% +447.0% +65.7% +152.4% -1.6% +8.8% +13.5%
+212.5% -68.7% +149.4% +230.1% +43.8% -26.6% +49.0% -71.2% +228.6%
+9,532.0%
+297.7% +149.2% -22.9% -34.2% -39.1% -43.5% +4.7%
+256.7% +35.1% +5.5% +20.8% +13.2% +0.9% +0.3% +0.3% +1.2%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?